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Background: In Germany, prostate cancer is the leading cause of cancer and the third leading cause of death
from cancer in males. We investigate prostate cancer in Germany among migrants from the Former Soviet
Union (FSU) and compare them to indigenous German population with regard to prostate cancer incidence,
mortality and longitudinal effects.
Methods: Data were obtained from two migrant cohorts residing in the federal states of North Rhine
Westphalia (n34,393) and Saarland (n18,619). Vital status was ascertained through local population
registries. Causes of death were obtained from the federal statistical office or from local health authorities.
Cancer incidence of the Saarland cohort was derived from the Saarland Cancer Registry using record linkage.
Results: From 1990 to 2005 we observed 3360 deaths of which 28 were due to prostate cancer. In the Saarland
cohort 35 men were diagnosed with prostate cancer during the respective period. Migrants had lower prostate
cancer incidence (SIR 0.74 (95% CI: 0.521.03)) and mortality (SMR 0.57 (95% CI: 0.380.83)) compared to
the German population. Multivariate analysis showed a strong age effect on incidence meaning young
migrants (below age 60) were diagnosed significantly more often with prostate cancer compared to Germans
of the same age. However, mortality did not show any effects.
Discussion: Lower prostate cancer mortality and incidence among the migrants may reflect an ongoing
situation in the FSU. Additionally, longitudinal analysis did not reveal convergence of migrant prostate
cancer to German rates as expected from lifestyle driven cancer sites. Therefore, our results support the
hypothesis of a genetic effect on prostate cancer risk.
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K
nown risk factors for prostate cancer explain
only a small proportion of all cases, and also
factors affecting the progression of the disease
are largely unknown. Male sex hormones and the aging
process contribute to the development of prostate cancer,
and a genetic predisposition has been discussed, because
of a higher incidence observed for several ethnic groups,
disease onset at a younger age, and family clustering of
the disease (1). There are few findings on risk factors
relating to lifestyle, diet or the environment. Possible risk
factors are high intakes of a-linolenic acid and calcium
(13). Additionally, there are studies showing an associa-
tion between an early onset prostate cancer risk and a
relatively high intake of total fat and fat derivatives, e.g.
Lophatananon et al. (4). Known lifestyle risk factors for
other cancer sites such as tobacco smoking, alcohol
consumption and low physical activity do not seem to
affect prostate cancer risk .
In Germany, prostate cancer is the most frequent
cancer (26%) and the third leading cause of death from
cancer in males (10%). Mean ages of diagnosis and death
from prostate cancer are about 70.1 years and 77.5 years,
respectively (5). Relative 5-year survival rates are about
90% (5).
Presently, there is a statutory screening programme for
prostate cancer in Germany. Men aged 45 years and over
are asked once a year by their physician if they have any
symptoms. This screening also includes an examination
of the sexual organs, the lymph nodes, as well as a
palpation examination of the prostate via the rectum. The
prostate-specific antigen (PSA) blood test is not part of
the statutory screening, however, more and more PSA
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Therefore, incidence trends began to continuously
increase. Since 1980, the age-standardised incidence rate
increased by 110% (6). In 2008, it was 82.7 per 100,000
men (standardised to Segi) (7, 8). On the other hand, age-
standardised mortality rates have been more or less stable
during the last decades and began to fall slightly since
1995. In 2006, the age-standardised mortality rate was
12.3 per 100,000 men (9).
Mortality of prostate cancer in Germany is among
the lowest in Europe, whereas incidence is around
the European average (10). Some of the lowest prostate
cancer rates with regard to mortality and incidence are
seen in South-East Asia. In contrast, Scandinavian
countries are among those with the highest prostate
cancer mortality worldwide. Prostate cancer mortality
rates are also estimated to be high in some African and
South American countries (8). A country-specific com-
parison shows that high prostate cancer incidence rates
do not necessarily mean high mortality rates and vice
versa (10).
In countries of the Former Soviet Union (FSU)
mortality from prostate cancer is lower compared to
Germany, however, during the last years the difference
shrinks continuously (see Fig. 1). In 2006, age-standar-
dised mortality rates were 5.7 in Kazakhstan, 10.1 in the
Russian Federation and 9.3 in Ukraine (9). Convergence
of German and FSU prostate cancer mortality is
probably due to differences in treatment, survival and
an overall increasing life expectancy in the FSU.
The FSU incidence from prostate cancer is much lower
compared to Germany. In 2008, age-standardised inci-
dence rates are estimated to be 10.9 in Kazakhstan, 26.1
in the Russian Federation and 20.3 in Ukraine (8). Low
incidence in countries of the FSU is likely to be the result
of fewer prostate specific antigen testing and maybe also
a general underestimation of cancer incidence. This
results in an incidence: mortality ratio of about 7 in
Germany and only about 2 in Kazakhstan, 2.5 in the
Russian Federation and 2 in Ukraine.
Since the beginning of the 1990’s more than two
million ethnic German migrants from the FSU came to
Germany. Previous studies revealed unanticipated mor-
tality patterns of these migrants: They had a lower overall
mortality, mainly determined by a low mortality from
cardiovascular disease (11, 12). In contrast, males had a
higher risk to die from external causes and deaths
associated with these causes such as mental and beha-
vioural disorders due to substance use (13). Overall
cancer mortality of migrants was similar to the German
population with great variations for specific cancer sites:
lung cancer was elevated among males, but lower among
females; stomach cancer was higher contrasting with
lower ratios for prostate cancer, male colorectal cancer
and female breast cancer. Based on an incomplete follow
up procedure cancer incidence rates of the migrants were
estimated to be similar to their mortality rates (14).
Several epidemiological studies on incidence and
mortality of migrants have led to new findings on the
etiology of diseases, but may also have important
implications with regard to development of targeted
cancer prevention and early detection strategies (1618).
In this study, we compare prostate cancer mortality of
two ethnic German migrant cohorts and prostate cancer
incidence of one cohort to the autochthonous German
population. Additionally, we investigated longitudinal
effects of age, calendar year and years since migration
to Germany which may help to understand (1) the health
care utilisation of the migrants and (2) the influence of
genetic versus lifestyle dependent effects. Converging
prostate cancer rates of the migrants may be expected if
lifestyle dependent factors influence the development of
disease, which has already been shown for stomach
cancer (19).
Fig. 1. Age-standardised prostate cancer mortality rates per 100,000 (Segi Standard).
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Study population
The study population consisted of two migrant cohorts
from the FSU residing in two different federal states of
Germany: North Rhine Westphalia (NRW) and Saarland.
To setup the NRW cohort routine data was provided
from the migrant reception centre of NRW. The original
dataset included all 281,356 ethnic German migrants
from countries of the FSU who settled in NRW between
1990 and 2001 and contained information on name, date
of birth, date of arrival in Germany, sex, countryof origin
and first city of residence. After sample size calculation
the cohort was restricted to a representative sample of
34,393 migrants according to the spatial distribution and
urban/rural proportion who were at least 15 years old
when they migrated to Germany. Selection procedures
and methodological details are described in detail else-
where (20).
The migrant reception centre of the Saarland could not
provide complete dataset with the above mentioned
information on the migrants. As an alternative, all local
refugee offices of the Saarland were contacted to get
access to their available data. Eligibility criteria for the
Saarland cohort were arrival between 1990 and 2005
from countries of the FSU. All together information on
26,384 migrants (more than 90% of all German migrants
who settled in the Saarland during the respective period)
were available. The dataset contained name, date of birth,
issue date of a German passport as an approximation for
date of migration, sex, country of birth for about 70% of
the cohort and first city of residence. The final cohort
consisted of a sample of 18,619 individuals with complete
information.
To ascertain vital status of each cohort member until
the 31st December 2005 a follow up procedure was
performed: letters were sent to local registry offices in the
cities of residence assessing the status of individuals. If
migrants moved, the new residence and date of moving
was provided. Then the local registry office of the
destination was contacted and so on until the individual
could be located. Changes of residence were recorded in a
database with the exact date of moving. In the case of
death, date and place of death were provided by the local
registry office.
Cause of death was either ascertained through a record
linkage system of the regional statistical office or through
local health authorities (21). In case of contacting local
health offices an anonymised copy of the relevant death
certificate was provided. Causes of death were coded
according to the International Classification of Diseases.
For the Saarland cohort a cancer incidence follow up
was directly done by the Saarland Cancer Registry.
Record linkage was performed using name, sex, date of
birth and place of residence. The possibility to change
surname and first name is often used by these migrants
during the first years of stay in Germany and did
therefore not allow a simple identification by name. To
minimise this problem matching procedure additionally
included the phonetic of the names. Forty-three cases
were not considered in the analysis because individuals
were already diagnosed with cancer in their country of
origin. All analyses were restricted to the first cancer,
multiple tumours were not considered.
Statistical methods
For evaluation of the migrants’ incidence and mortality
in comparison to the host population reference rates are
needed. Analysis of mortality was done in comparison to
the German population as standardised mortality ratio
(SMR). German mortality rates were calculated using
the WHO mortality database (9). For calculation of the
standardised incidence ratio (SIR) we used data from the
Saarland Cancer Registry which has population figures
and incidence data for the full observation period 1990
2005. Person-time was computed as person-years (PY) to
calculate the expected number of cases for indirect
standardization. Exact 95% confidence intervals for
SMR and SIR were calculated.
In a multivariable model we analysed simultaneously
the effects of age group, calendar year, and years since
migration to Germany. The effect of these covariables on
(1) incidence rates, (2) mortality rates, (3) SIR and (4)
SMR was modelled with Poisson regression (22). The
covariable effects for each variable separately and for
the model overall was given by likelihood-ratio tests. Age
standardised rates were adjusted to the Segi population.
For mortality analysis additionally the variable ‘cohort’
(NRW or Saarland) was considered. Analysis was per-
formed using SAS version 9.2.
Results
Descriptive characteristics of both cohorts and results of
the follow up procedure are presented in Table 1. The
Saarland cohort was about half the size of the cohort in
NRW. The arrival period for entering the cohort was four
years longer for the Saarland cohort. The NRW study
population was restricted by age at migration of 15 years
or older; the Saarland cohort had no age restriction.
Thus, the Saarland cohort was on average younger.
Country of origin distribution was similar for both
cohorts: around 55% of the migrants came from Kazakh-
stan, 37% from the Russian Federation. Other countries
of the FSU contributed each less than 5%.
Overall, the NRW cohort accumulated 346,671.5 PY
and the Saarland cohort 148,313.1 PY. Follow up of the
NRW cohort was complete for 96.7% of the cohort
members with a mean follow up time of 10.1 years.
Overall 2,580 (7.5%) cohort members died. Causes of
death were known for 94.8% of deceased persons. Also
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observation period, which means their last date of
contact was censored. Individuals became lost follow
up due to different reasons: moving abroad or moving to
an unknown destination or insufficient data of the
population registries.
In the Saarland cohort vital status was known for
77.4% of individuals. Mean follow up time was 8 years,
while 87% of the lost individuals were censored at the day
of leaving the study area because of moving to another
federal state. Since the Saarland is a rather small state
people are much more likely to move to another state
compared to larger ones such as NRW. During the
observation period 780 (4.2%) persons died. Cause of
deaths was known through the Saarland Cancer Registry
for all individuals diagnosed with cancer and those who
died from cancer without prior diagnosis (death certifi-
cate only (DCO) cases). Between 1990 and 2005 448
cohort members of the Saarland cohort were diagnosed
with a malignant neoplasm.
During the observation period 28 men died from
prostate cancer in both cohorts. Their mean age of death
was 76.9 years (Range: 60.892.1). In the Saarland cohort
35 men were diagnosed with prostate cancer. Mean age of
diagnosis was 67.6 years (Range: 45.385.8). Figure 2
displays follow up of all 35 incident prostate cancer cases
starting with their migration to Germany, their age at
diagnosis and their vital status at end of follow up. Most
cases were alive at the end of the observation period. Two
patients left Saarland and nine died during the observa-
tion period. Three of the deceased men died from
prostate cancer; one of these was not registered during
lifetime (DCO case).
Multivariate Poisson regression showed that mortality
rates did not change appreciably over time. Age standar-
dised mortality was 44.1 (95% CI: 32.062.1) per 100,000
individuals, respectively (see Fig. 1).
In comparison with the German resp. state of Saarland
population we found that mortality from prostate cancer
was strongly reduced among the migrantswith an SMRof
0.57 (95% CI: 0.380.83, pB0.001, both cohorts com-
bined). Prostate cancer incidence was also reduced among
themigrantswithaSIRof0.74,however,theresultwasnot
significant (95% CI: 0.521.03, p0.076) (see Table 2).
In further analysing the SMR, Poisson regression
analysis showed little and insignificant effects of the
considered covariables calendar year, years since migra-
tion, age and ‘cohort’ on the SMR (data not shown).
Results of modelling the SIR are shown in Table 3.
Calendar year and age had a significant effect, while time
since immigration showed no effect. The SIR decreased
with increasing age and with increasing calendar year
(models 2.1 and 2.2). This means that the incidence
relative to the corresponding German population was
most different for the old ages and for the early years of
immigration. An interaction effect between age and year
could not be seen, which, however, was unlikely given the
low sample size (models 3.1 and 3.2).
Discussion
The aim of the study was to analyse prostate cancer
mortality and incidence among ethnic German migrants
who came to Germany from the FSU since the year 1990.
Therefore, we analysed two cohorts of migrants in terms
of prostate cancer mortality and incidence including
longitudinal and age effects. As one main result we found
that these migrants had significantly lower prostate
cancer incidence and mortality compared to the German
population.
Table 1. Descriptive results of both migrant cohorts, from
North-Rhine Westphalia and Saarland
Migrant cohort in the
Federal State of NRW






Males (%) 16,734 (48.7%) 8,977 (48.2%)
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tical analysis have been discussed in detail elsewhere (11,
14, 20). In brief, both cohort studies have the pros and
cons of historical cohort studies. It was possible to give
valid estimates of the migrant’s mortality and incidence in
terms of SMR and SIR. Indirect standardisation has
proven to be more precise for rare outcomes compared to
the direct standardisation method meaning the calcula-
tion of rates (23). However, we had only access to routine
data and no information on access of health care or other
lifestyle-related risk factors.
The analysis of prostate cancer mortality and incidence
showed several different aspects. First, the descriptive
comparison of the migrants’ mean age of death from
prostate cancer to the Saarland population showed no
difference with 76.9 and 77.5 years of age, respectively.
However, mean age of diagnosis was 2.5 years earlier
among the migrants.
Overall evaluation of prostate cancer showed lowered
mortality in comparison to the German population.
Based on regression analysis the estimated age-standar-
dised mortality rates of the migrants were close to rates
observed in the FSU (Fig. 1). Multivariate analysis did
not show any longitudinal trends or difference to the age-
specific prostate cancer mortality of the German popula-
tion. However, we cannot rule out that this was due to the
relatively small number of observed deaths.
Prostate cancer diagnosis was also reduced among the
migrants, but not significantly. Incidence rates among
the migrants were constant in contrast to German
incidence which rises contiguously since the 1980s. Multi-
variate Poisson regression confirmed reduced diagnosis
with calendar time in comparison to the German
population especially among old migrants. A possible
explanation might be differences in health seeking such as
lower use of prostate cancer screening in younger
migrants, however, there is no data available to check
this hypothesis. In general, one has to be aware that
Fig. 2. Overview of all 35 incident prostate cancer cases from the Saarland cohort sorted by age at diagnosis.
Table 2. Standardised incidence and mortality ratios of the






35 47.3 0.74 (0.521.03)
Mortality (both
cohorts)
28 48.7 0.57 (0.380.83)
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rate than the true incidence rate.
Ethnic German migrants from the FSU are a unique
group of diaspora migrants. There are hardly any other
examples in the world where such a big ethnic group has
migrated in this short time period from one country to
another. Prostate cancer mortality and incidence was
lower among the migrants and somehow reflect the
situation in the FSU. Additional analysis did not yet
reveal any convergence of their prostate cancer mortality
compared to German rates as it would be expected from
lifestyle driven cancer sites. Therefore, our results may
support the hypothesis of a genetic component on the
development of prostate cancer. However, we cannot rule
out that this is due to the limited number of observations.
There are few studies on Asian migrants living in the
United States reporting increased prostate cancer inci-
dence among those migrants compared to their countries
of origin presumably due to changes in lifestyle and diet
(24). On the other hand, prostate cancer rates of Asian
migrants remain very low. Therefore increased rates
might also be due to better detection.
The results also hint to the hypothesis that ethnic
German migrants from the FSU are genetically different
to the German population, which might be the result of
positive or negative selection usually occurring during a
migration process (25). However, previous analysis re-
vealed hardly any selection of the migrants when the
came to Germany after the fall of the Iron Curtain in
1989. So we believe selection might have occurred when
the migrants went to Russia about 200 years ago (26).
Yet, there are no studies about genetic differences on
FSU migrants.
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